Who
Prathyusha Duraibabu
Director
Company insider
Files Form 4 as: Director, Organogenesis Holdings; Principal Financial Officer, Sangamo Therapeutics.
In numbers
- Trades disclosed
- 62
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 25 Feb 2020
- Last trade
- 18 Feb 2026
- Last filed
- 20 Feb 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 18 Feb 2026filed 20 Feb 2026 | ORGO Organogenesis HoldingsBiotechnology | SEC FORM 4 Code A | —48,828 at $0.00 | filing |
| 18 Feb 2026filed 20 Feb 2026 | ORGO Organogenesis HoldingsBiotechnology | SEC FORM 4 Code A | —48,828 at $0.00 | filing |
| 22 Jan 2026filed 26 Jan 2026 | Sangamo TherapeuticsBiotechnology | SEC FORM 4 Code F | $15K36,676 at $0.3985 | filing |
| 22 Jan 2026filed 26 Jan 2026 | Sangamo Therapeutics | SEC FORM 4 Code F | $15K36,676 at $0.40 | filing |
| 24 Nov 2025filed 26 Nov 2025 | Sangamo Therapeutics | SEC FORM 4 Code F | $1,0682,544 at $0.42 | filing |
| 22 Oct 2025filed 24 Oct 2025 | Sangamo Therapeutics | SEC FORM 4 Code F | $30K45,225 at $0.66 | filing |
| 24 Aug 2025filed 26 Aug 2025 | Sangamo Therapeutics | SEC FORM 4 Code F | $1,0571,792 at $0.59 | filing |
| 22 Jul 2025filed 24 Jul 2025 | Sangamo Therapeutics | SEC FORM 4 Code F | $15K31,866 at $0.48 | filing |
| 24 May 2025filed 28 May 2025 | Sangamo Therapeutics | SEC FORM 4 Code F | $8421,792 at $0.47 | filing |
| 22 Apr 2025filed 24 Apr 2025 | Sangamo Therapeutics | SEC FORM 4 Code F | $25K31,866 at $0.78 | filing |
| 25 Feb 2025filed 26 Feb 2025 | Sangamo Therapeuticsoption or derivative | SEC FORM 4 Code A | —560,000 at $0.00 | filing |
| 25 Feb 2025filed 26 Feb 2025 | Sangamo Therapeutics | SEC FORM 4 Code F | $1,3201,375 at $0.96 | filing |
| 25 Feb 2025filed 26 Feb 2025 | Sangamo Therapeutics | SEC FORM 4 Code A | —120,000 at $0.00 | filing |
| 24 Feb 2025filed 26 Feb 2025 | Sangamo Therapeutics | SEC FORM 4 Code F | $1,7921,792 at $1.00 | filing |
| 19 Feb 2025filed 21 Feb 2025 | ORGO Organogenesis HoldingsBiotechnology | SEC FORM 4 Code A | —49,575 at $0.00 | filing |
| 22 Jan 2025filed 24 Jan 2025 | Sangamo Therapeutics | SEC FORM 4 Code F | $149K129,242 at $1.15 | filing |
| 25 Nov 2024filed 26 Nov 2024 | Sangamo Therapeutics | SEC FORM 4 Code F | $2,6601,371 at $1.94 | filing |
| 24 Nov 2024filed 26 Nov 2024 | Sangamo Therapeutics | SEC FORM 4 Code F | $3,3601,787 at $1.88 | filing |
| 25 Aug 2024filed 27 Aug 2024 | Sangamo Therapeutics | SEC FORM 4 Code F | $1,1791,371 at $0.86 | filing |
| 24 Aug 2024filed 27 Aug 2024 | Sangamo Therapeutics | SEC FORM 4 Code F | $1,5371,787 at $0.86 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.